| Literature DB >> 29062564 |
Mohammed S Al-Azri1, Jazel Manarang2, Yaqoub Al-Mufargi3.
Abstract
To this day, tuberculosis (TB) continues to pose a significant global health burden. The World Health Organization's Expanded Programme on Immunization (EPI) recommends the bacille Calmette-Guérin (BCG) vaccine for infants to protect against the haematogenous spread of primary TB and other more severe types of TB infection. We report an eight-month-old boy who presented to the Armed Forces Hospital, Muscat, Oman, in 2015 with a one-month history of intermittent fever associated with a limited range of motion in the right hip area. He was up-to-date with his EPI vaccinations and had no history of exposure to individuals with TB infections. He was initially treated for bacterial septic arthritis; however, a GeneXpert TB assay revealed the presence of Mycobacterium tuberculosis, BCG strain. To the best of the authors' knowledge, this is the first documented case from Oman of a child with TB hip osteomyelitis due to a BCG vaccination.Entities:
Keywords: BCG Vaccine; Case Report; Oman; Osteomyelitis; Tuberculosis; Vaccination; adverse effects
Mesh:
Substances:
Year: 2017 PMID: 29062564 PMCID: PMC5642371 DOI: 10.18295/squmj.2017.17.03.019
Source DB: PubMed Journal: Sultan Qaboos Univ Med J ISSN: 2075-051X